Larvol Delta - ADAMANT-24-Months-Safety-and-Efficacy-Study-of-AADvac1-in-Patients-With-Mild-Alzheimer39s-Disease

AADvac1 - Axon Neurosci

http://clinicaltrials.gov/ct2/show/NCT02579252

Nov 15, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next